PT  - JOURNAL ARTICLE
AU  - Appa, Ayesha
AU  - Chamie, Gabriel
AU  - Sawyer, Aenor
AU  - Baltzell, Kimberly
AU  - Dippell, Kathryn
AU  - Ribeiro, Salu
AU  - Duarte, Elias
AU  - Vinden, Joanna
AU  - ,
AU  - Kramer-Feldman, Jonathan
AU  - Rahdar, Shahryar
AU  - MacIntosh, Doug
AU  - Nicholson, Katherine
AU  - Im, Jonathan
AU  - Havlir, Diane
AU  - Greenhouse, Bryan
TI  - SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures
AID  - 10.1101/2020.05.29.20116426
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.29.20116426
4099  - http://medrxiv.org/content/early/2020/05/30/2020.05.29.20116426.short
4100  - http://medrxiv.org/content/early/2020/05/30/2020.05.29.20116426.full
AB  - High-volume, community-wide ascertainment of SARS-CoV-2 prevalence by PCR and antibody testing was successfully performed using a community-led, drive-through model with strong operational support, well-trained testing units, and an effective technical platformCompeting Interest StatementThe authors have declared no competing interest.Funding StatementFinancial Support This work was primarily supported by the Bolinas Community Land Trust. Additional sources of support included funding from the Chan Zuckerberg Biohub Investigator program (BG) and the National Institutes of Health grant 5T32AI007641-17 (AA). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Approval The aforementioned procedures were submitted to the University of California San Francisco institutional review board for approval, and the study was deemed public health surveillance not requiring IRB oversight [IRB number 20-30636]. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis manuscript does not contain patient-level data.